Pharmacokinetic properties of mezlocillin in ambulatory elderly subjects.

Abstract

Twelve healthy ambulatory elderly subjects (mean age, 73-78 years) randomly received either a 4-g or 5-g dose of mezlocillin intravenously. One week later the regimen was repeated and patients crossed over to the other dose. Peak serum concentrations were 165 mg/L and 281 mg/L for the 4-g and 5-g doses, respectively. For both doses, differences in t1/2 beta (1.32 hr vs 1.13 hr), AUC (275 mg.hr/L vs 403 mg.hr/L), CL (207 mL/min vs 174 mL/min), CLR (59 mL/min vs 45 mL/min), CLNR (152 mL/min vs 130 mL/min) were not statistically significant. The differences in Varea (22.4L vs 168.8L, P less than or equal to .01) and Cmax (216.6 mg/L vs 317 mg/L, P less than or equal to .05) were statistically significant. Comparison with pharmacokinetic parameters obtained in younger subjects following the 5-g dose reveals that in the elderly the AUC, Varea, and CLNR are higher whereas the CL and CLR are lower. The elderly demonstrated an increase in nonrenal clearance compared with young subjects that is not fully compensatory. The increased AUC in the elderly group suggests that clinical studies examining mezlocillin doses and dose intervals in the treatment of serious infections are warranted in infected elderly patients.

• Authors: B R Meyers, M H Mendelson, E Srulevitch-Chin, K Bradbury, L McMurdo, S Z Hirschman
• Journal: Journal of clinical pharmacology (J Clin Pharmacol) Vol. 27 Issue 9 Pg. 678-81 (Sep 1987) ISSN: 0091-2700 [Print] England
• PMID: 3680597 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Mezlocillin

Topics

• Aged
• Aged, 80 and over
• Humans
• Infusions, Intravenous
• Mezlocillin (blood, pharmacokinetics, urine)
• Random Allocation
• Reference Values